WO2006122075A1 - Intravascular filter with drug reservoir - Google Patents
Intravascular filter with drug reservoir Download PDFInfo
- Publication number
- WO2006122075A1 WO2006122075A1 PCT/US2006/017821 US2006017821W WO2006122075A1 WO 2006122075 A1 WO2006122075 A1 WO 2006122075A1 US 2006017821 W US2006017821 W US 2006017821W WO 2006122075 A1 WO2006122075 A1 WO 2006122075A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- filter
- intravascular filter
- intravascular
- apical head
- legs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/0105—Open ended, i.e. legs gathered only at one side
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/005—Rosette-shaped, e.g. star-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0067—Three-dimensional shapes conical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
Definitions
- the invention relates generally to filters and relates more specifically to filters such as intravascular filters that include a drug reservoir.
- Intravascular filters can be used to treat vascular conditions such as pulmonary embolism. These devices can be inserted intravenously into a target location of the body such as an artery or vein, and can capture blood clots (emboli) contained in the blood stream before they can reach the heart and/or lungs and cause permanent damage to the body.
- An intravascular filter can be placed percutaneously via an introducer sheath through the femoral arteries or the jugular vein using a local anesthetic, or by performing a laparotomy with the patient under general anesthesia.
- intravascular filters such as vena cava filters are known. However, a need remains for improved designs. A need remains for intravascular filters having improved ability to dissolve or lyse captured emboli.
- the present invention is directed to an intravascular filter that captures and eliminates emboli.
- an illustrative embodiment of the present invention can be found in an intravascular filter that has a plurality of filter legs. Each filter leg has a free end and an opposite joined end.
- the intravascular filter also has an apical head. The joined end of each of the filter legs is joined to the apical head and each of the filter legs radiate outwardly from the apical head.
- a drug reservoir that includes or contains a therapeutic drug is disposed near the apical head.
- Another illustrative embodiment of the present invention can be found in a method of dissolving embolic debris within a vasculature.
- An intravascular filter having an apical head and a drug reservoir positioned at or near the apical head is deployed.
- the drug reservoir includes a thrombolytic drug.
- the thrombolytic drug is eluted from the drug reservoir in response to an emboli contacting the drug reservoir, thereby dissolving the embolic debris.
- Figure 1 is a perspective view of an intravascular filter in accordance with an illustrative embodiment of the present invention
- Figure 2 is a perspective view of an intravascular filter in accordance with another illustrative embodiment of the present invention.
- Figure 3 is a partial cross-sectional view of the intravascular filter of Figure 1, shown in delivery configuration within an introducer sheath;
- Figure 4 is a partial cross-sectional view of the intravascular filter of Figure 1, shown deployed.
- Figure 5 is a partial cross-sectional view of the intravascular filter of Figure 1, shown deployed in position to capture emboli.
- FIG. 1 is a perspective view of an intravascular filter 10.
- the intravascular filter 10 includes an apical head 12 and several filter legs 14. Each of the filter legs 14 has a joined end 16 and a free end 18. The joined end 16 of each filter leg 14 may be joined to the apical head 12. In some instances, the joined end 16 may be laser welded to the apical head 12, although other attachment methods may be used as appropriate.
- the intravascular filter 10 may have three, four, five, six, or more filter legs 14. In some cases, the filter legs 14 may be arranged in opposing pairs. In some instances, as illustrated, a hook or barb 20 may be located at the free end 18 of each filter leg 14 to facilitate positioning and securing the intravascular filter 10 in a suitable intra- vascular location.
- the intravascular filter 10 can be formed of any suitable material. In some embodiments, it can be useful to form the intravascular filter 10 of a metallic material that permits compression of the intravascular filter 10 into a delivery configuration while allowing the intravascular filter 10 to regain its deployment configuration after the intravascular filter 10 has been deployed. Suitable metals include platinum, gold, tantalum, tungsten, titanium, or stainless steel, and shape memory materials such as nickel-titanium alloys. In particular, the intravascular filter 10 can be formed of nickel-titanium alloys, stainless steel enriched with platinum, MP35N, cobalt- chromium-nickel-molyodenum-iron alloy specified by ASTM F1058 and ISO 5832-7 or other suitable material.
- the intravascular filter 10 also includes a drug reservoir 22.
- the drug reservoir 22 may be positioned near the apical head 12 at a position that is at least substantially interior to the filter legs 14.
- the drug reservoir 22 may include or contain a therapeutic drug such as a thrombolytic agent and/or an anti-coagulant.
- thrombolytic agents include serine proteases such as reteplase (either r-PA or Retavase),reteplase (t-PA or Activase), urokinase (Abbokinase), prourokinase, anisoylated streptokinase activator complex, and streptokinase.
- serine proteases such as reteplase (either r-PA or Retavase),reteplase (t-PA or Activase), urokinase (Abbokinase), prourokinase, anisoylated streptokinase activator complex, and streptokinase.
- suitable anti-coagulants include heparin or Coumadin.
- the drug reservoir may be formed from a therapeutic agent that is dispersed within a polymer that is designed to permit elution of the therapeutic agent.
- a polymer that is designed to permit elution of the therapeutic agent.
- Any suitable polymer may be used.
- the polymer may be poly(styrene-b-isobutylene-b-styrene), or SIBS. This material is commercially available from Boston Scientific Corporation under the tradename TRANSLUTETM. This is a hydrophobic elastomeric tri-block copolymer that is based upon l,3-di(2- methoxy-2-propyl)-5-tert-butylbenzene).
- SIBS has a number-average molecular weight of about 80,000 to 130,000 grams per mole.
- the drug reservoir 22 may be formed in any suitable manner.
- the drug reservoir 22, containing or formed from a therapeutic agent dispersed within a polymer may be formed in place near the apical head 12 by dipping, spraying or any other suitable technique.
- the drug reservoir 22 may extend outwardly from the interior of the space defined by the filter legs 14 and may in fact at least partially encapsulate the apical head 14.
- a plug or other similar shape containing the therapeutic agent dispersed within the polymer may be independently formed and shaped, and subsequently inserted into position within the intravascular filter 10.
- FIG 2 is a perspective view of an intravascular filter 24 in accordance with another embodiment of the present invention. Construction of the intravascular filter 24 is essentially the same as the intravascular filter 10 discussed with respect to Figure 1, with the exception of the drug reservoir 26.
- the intravascular filter 24 includes an apical head 12 and a plurality of filter legs 14. Each filter leg 14 has a joined end 16 and a free end 18 bearing a hook or barb 20. The joined end 16 of each filter leg 14 is secured to the apical head 12.
- the intravascular filter 24 differs, however, in the form and construction of the drug reservoir 26.
- the drug reservoir 26 takes the form of a bowl or cup having a closed end 28 positioned relatively closer to the apical head 12 and an open end 30 positioned relatively farther from the apical head 12.
- the drug reservoir 26 may be formed of any suitable material. Examples of suitable materials include plastics and metals such as stainless steel and nitinol.
- the drug reservoir 26 may be secured to the intravascular filter 24 in any suitable manner, including welding or the use of adhesives.
- the intravascular filter 24 In use, the intravascular filter 24 would be positioned such that blood would flow from the free end 18 of the filter legs 14 towards the apical head 12. As a result, emboli captured by the intravascular filter 24 will be carried by blood flow towards the apical head 12 and thus will contact the open end 30 of the drug reservoir 26.
- a therapeutic drug such as those discussed previously with respect to the drug reservoir 22 ( Figure 1) may be eluted or released in response to the emboli contacting the drug reservoir 26.
- a therapeutic coating onto the filter legs 14 and/or the apical head 12 to further facilitate dissolution of any captured emboli.
- Any suitable coating may be applied. Examples of suitable coatings include drugs, chemotherapeutics, antibiotics, and the like.
- appropriate substances may include anti-thrombogenic agents and/or anticoagulants such as heparin, Coumadin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone) D- Phe-Pro-Arg chloromethyl keton, an RGD peptide-containing compound, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, antiplatelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors, and tick antiplatelet peptides; anti-proliferative agents such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine; antineoplastic/antiprolife
- Figures 3-5 illustrate deployment and use of the intravascular filter 10 (Figure 1), although the intravascular filter 24 ( Figure 2) can be deployed and used in a similar manner.
- the intravascular filter 10 is schematically illustrated in a collapsed or delivery configuration within an introducer sheath 32 having a distal end 34.
- the intravascular filter 10 can be delivered to the physician or other healthcare professional preloaded into the introducer sheath 32.
- it is considered that the intravascular filter 10 can be loaded into the introducer sheath 32 just prior to insertion of the introducer sheath 32 into a vessel 36.
- the introducer sheath 32 may be formed of any suitable materials and having any suitable construction, as is known in the art.
- the intravascular filter 10 can be moved distally using any conventionally known technique.
- a pusher sheath 38 having a distal end 40 may be positioned within the introducer sheath 32 and can be used to push against the intravascular filter 10 to urge the intravascular filter 10 distally. It is contemplated that the distal end 40 of the pusher sheath 38 may be configured to accommodate the apical head 12 of the intravascular filter 10.
- the pusher sheath 38 may be formed of any suitable materials and having any suitable construction, as is known in the art.
- the pusher sheath 38 can hold the intravascular filter 10 while the introducer sheath 32 is withdrawn proximally in order to deploy the intravascular filter 10.
- a pressurized fluid such as saline may be used to urge the intravascular filter 10 distally.
- Figure 4 illustrates the intravascular filter 10 in a fully deployed configuration. In Figure 4, it can be seen that the hooks or barbs 20 that are present at the free ends 19 of the filter legs 14 engage with a vessel wall 42 of the blood vessel 36.
- Figure 5 illustrates the intravascular filter 10 deployed within a patient's vessel 36 in which blood flow is indicated by arrows 42.
- the apical head 12 and drug reservoir 22 is downstream of an open end of the intravascular filter 10 defined by the free ends 18 of the filter legs 14.
- An emboli 44 is seen moving towards the intravascular filter 10. As the emboli 44 moves closer, it will be guided by the filter legs 14 towards the center of the intravascular filter 10 and thus towards the drug reservoir 22.
- the drug reservoir may elute a therapeutic drug, such as those discussed above, in order to facilitate dissolution of the emboli 44.
Abstract
An intravascular filter can capture and eliminate emboli. In particular, an intravascular filter may include a plurality of filter legs extending from an apical head. The filter legs may be configured to capture emboli. A drug reservoir that includes or contains a therapeutic drug can be disposed near the apical head. The therapeutic drug, such as a thrombolytic or anti-coagulatory drug, may be eluted in response to a captured emboli.
Description
INTRAVASCULAR FILTER WITH DRUG RESERVOIR
Technical Field
The invention relates generally to filters and relates more specifically to filters such as intravascular filters that include a drug reservoir.
Background
Intravascular filters can be used to treat vascular conditions such as pulmonary embolism. These devices can be inserted intravenously into a target location of the body such as an artery or vein, and can capture blood clots (emboli) contained in the blood stream before they can reach the heart and/or lungs and cause permanent damage to the body. An intravascular filter can be placed percutaneously via an introducer sheath through the femoral arteries or the jugular vein using a local anesthetic, or by performing a laparotomy with the patient under general anesthesia.
A variety of intravascular filters such as vena cava filters are known. However, a need remains for improved designs. A need remains for intravascular filters having improved ability to dissolve or lyse captured emboli.
Summary
The present invention is directed to an intravascular filter that captures and eliminates emboli.
Accordingly, an illustrative embodiment of the present invention can be found in an intravascular filter that has a plurality of filter legs. Each filter leg has a free end and an opposite joined end. The intravascular filter also has an apical head. The joined end of each of the filter legs is joined to the apical head and each of the filter legs radiate outwardly from the apical head. A drug reservoir that includes or contains a therapeutic drug is disposed near the apical head.
Another illustrative embodiment of the present invention can be found in a method of dissolving embolic debris within a vasculature. An intravascular filter having an apical head and a drug reservoir positioned at or near the apical head is deployed. The drug reservoir includes a thrombolytic drug. The thrombolytic drug is eluted from the drug reservoir in response to an emboli contacting the drug reservoir, thereby dissolving the embolic debris.
The above summary of the present invention is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures,
Detailed Description and Examples which follow more particularly exemplify these embodiments.
Brief Description of the Figures
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
Figure 1 is a perspective view of an intravascular filter in accordance with an illustrative embodiment of the present invention;
Figure 2 is a perspective view of an intravascular filter in accordance with another illustrative embodiment of the present invention;
Figure 3 is a partial cross-sectional view of the intravascular filter of Figure 1, shown in delivery configuration within an introducer sheath;
Figure 4 is a partial cross-sectional view of the intravascular filter of Figure 1, shown deployed; and
Figure 5 is a partial cross-sectional view of the intravascular filter of Figure 1, shown deployed in position to capture emboli.
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
Detailed Description
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term "about", whether or not explicitly indicated. The term "about" generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value, i.e., having the same function or result. In many instances, the term "about" may include numbers that are rounded to the nearest significant figure.
As used in this specification and in the appended claims, the singular forms "a", "an", and "the" include plural referents unless the content clearly dictates otherwise. As used in this specification and in the appended claims, the term "or" is
generally employed in its sense including "and/or" unless the content clearly dictates otherwise.
The following description should be read with reference to the drawings, in which like elements in different drawings are numbered in like fashion. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. Although examples of construction, dimensions, and materials are illustrated for the various elements, those skilled in the art will recognize that many of the examples provided have suitable alternatives that may be utilized.
Figure 1 is a perspective view of an intravascular filter 10. For illustrative but non-limiting purposes, the present invention will be discussed with respect to vena cava filters. The intravascular filter 10 includes an apical head 12 and several filter legs 14. Each of the filter legs 14 has a joined end 16 and a free end 18. The joined end 16 of each filter leg 14 may be joined to the apical head 12. In some instances, the joined end 16 may be laser welded to the apical head 12, although other attachment methods may be used as appropriate. The intravascular filter 10 may have three, four, five, six, or more filter legs 14. In some cases, the filter legs 14 may be arranged in opposing pairs. In some instances, as illustrated, a hook or barb 20 may be located at the free end 18 of each filter leg 14 to facilitate positioning and securing the intravascular filter 10 in a suitable intra- vascular location.
The intravascular filter 10 can be formed of any suitable material. In some embodiments, it can be useful to form the intravascular filter 10 of a metallic material that permits compression of the intravascular filter 10 into a delivery configuration while allowing the intravascular filter 10 to regain its deployment configuration after the intravascular filter 10 has been deployed. Suitable metals include platinum, gold, tantalum, tungsten, titanium, or stainless steel, and shape memory materials such as nickel-titanium alloys. In particular, the intravascular filter 10 can be formed of nickel-titanium alloys, stainless steel enriched with platinum, MP35N, cobalt- chromium-nickel-molyodenum-iron alloy specified by ASTM F1058 and ISO 5832-7 or other suitable material.
The intravascular filter 10 also includes a drug reservoir 22. As illustrated in Figure 1, the drug reservoir 22 may be positioned near the apical head 12 at a position that is at least substantially interior to the filter legs 14. In some instances, the drug
reservoir 22 may include or contain a therapeutic drug such as a thrombolytic agent and/or an anti-coagulant.
Examples of suitable thrombolytic agents include serine proteases such as reteplase (either r-PA or Retavase), alteplase (t-PA or Activase), urokinase (Abbokinase), prourokinase, anisoylated streptokinase activator complex, and streptokinase. Examples of suitable anti-coagulants include heparin or Coumadin.
In some instances, the drug reservoir may be formed from a therapeutic agent that is dispersed within a polymer that is designed to permit elution of the therapeutic agent. Any suitable polymer may be used. In some instances, the polymer may be poly(styrene-b-isobutylene-b-styrene), or SIBS. This material is commercially available from Boston Scientific Corporation under the tradename TRANSLUTE™. This is a hydrophobic elastomeric tri-block copolymer that is based upon l,3-di(2- methoxy-2-propyl)-5-tert-butylbenzene). SIBS has a number-average molecular weight of about 80,000 to 130,000 grams per mole.
The drug reservoir 22 may be formed in any suitable manner. In some instances, the drug reservoir 22, containing or formed from a therapeutic agent dispersed within a polymer, may be formed in place near the apical head 12 by dipping, spraying or any other suitable technique. In such cases, the drug reservoir 22 may extend outwardly from the interior of the space defined by the filter legs 14 and may in fact at least partially encapsulate the apical head 14. In other cases, a plug or other similar shape containing the therapeutic agent dispersed within the polymer may be independently formed and shaped, and subsequently inserted into position within the intravascular filter 10.
Figure 2 is a perspective view of an intravascular filter 24 in accordance with another embodiment of the present invention. Construction of the intravascular filter 24 is essentially the same as the intravascular filter 10 discussed with respect to Figure 1, with the exception of the drug reservoir 26. The intravascular filter 24 includes an apical head 12 and a plurality of filter legs 14. Each filter leg 14 has a joined end 16 and a free end 18 bearing a hook or barb 20. The joined end 16 of each filter leg 14 is secured to the apical head 12.
The intravascular filter 24 differs, however, in the form and construction of the drug reservoir 26. In this embodiment, the drug reservoir 26 takes the form of a bowl or cup having a closed end 28 positioned relatively closer to the apical head 12 and an open end 30 positioned relatively farther from the apical head 12. The drug reservoir
26 may be formed of any suitable material. Examples of suitable materials include plastics and metals such as stainless steel and nitinol. The drug reservoir 26 may be secured to the intravascular filter 24 in any suitable manner, including welding or the use of adhesives.
In use, the intravascular filter 24 would be positioned such that blood would flow from the free end 18 of the filter legs 14 towards the apical head 12. As a result, emboli captured by the intravascular filter 24 will be carried by blood flow towards the apical head 12 and thus will contact the open end 30 of the drug reservoir 26. A therapeutic drug such as those discussed previously with respect to the drug reservoir 22 (Figure 1) may be eluted or released in response to the emboli contacting the drug reservoir 26.
In some instances, it may be useful to also provide a therapeutic coating onto the filter legs 14 and/or the apical head 12 to further facilitate dissolution of any captured emboli. Any suitable coating may be applied. Examples of suitable coatings include drugs, chemotherapeutics, antibiotics, and the like.
Some examples of appropriate substances may include anti-thrombogenic agents and/or anticoagulants such as heparin, Coumadin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone) D- Phe-Pro-Arg chloromethyl keton, an RGD peptide-containing compound, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, antiplatelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors, and tick antiplatelet peptides; anti-proliferative agents such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine; antineoplastic/antiproliferative/anti-miotic agents such as paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors; anesthetic agents such as lidocaine, bupivacaine, and ropivacaine; vascular cell growth inhibitors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin; cholesterol-lowering agents; vasodilating agents; agents which interfere with endogenous vascoactive mechanisms; anti-sense
DNA and RNA; and DNA coding for (and the corresponding proteins) anti-sense RNA, tRNA or rRNA to replace defective or deficient endogenous molecules, angiogenic factors including growth factors such as acidic and basic fibroblast growth factors, vascular endothelial growth factor, epidermal growth factor, transforming growth factor α and β, platelet-derived endothelial growth factor, platelet-derived growth factor, tumor necrosis factor α, hepatocyte growth factor and insulin like growth factor, cell cycle inhibitors including CD inhibitors, thymidine kinase ("TK") and other agents useful for interfering with cell proliferation, and the family of bone morphogenic proteins ("BMP's") including BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (OP-I), BMP-8, BMP-9, BMP-IO, BMP-Il, BMP- 12, BMP-13, BMP-14, BMP-15, BMP-16, "hedgehog" proteins.
Returning to the Figures, Figures 3-5 illustrate deployment and use of the intravascular filter 10 (Figure 1), although the intravascular filter 24 (Figure 2) can be deployed and used in a similar manner. In Figure 3, the intravascular filter 10 is schematically illustrated in a collapsed or delivery configuration within an introducer sheath 32 having a distal end 34. In some embodiments, the intravascular filter 10 can be delivered to the physician or other healthcare professional preloaded into the introducer sheath 32. In other embodiments, it is considered that the intravascular filter 10 can be loaded into the introducer sheath 32 just prior to insertion of the introducer sheath 32 into a vessel 36. The introducer sheath 32 may be formed of any suitable materials and having any suitable construction, as is known in the art.
The intravascular filter 10 can be moved distally using any conventionally known technique. For example, a pusher sheath 38 having a distal end 40 may be positioned within the introducer sheath 32 and can be used to push against the intravascular filter 10 to urge the intravascular filter 10 distally. It is contemplated that the distal end 40 of the pusher sheath 38 may be configured to accommodate the apical head 12 of the intravascular filter 10. The pusher sheath 38 may be formed of any suitable materials and having any suitable construction, as is known in the art.
In some embodiments, the pusher sheath 38 can hold the intravascular filter 10 while the introducer sheath 32 is withdrawn proximally in order to deploy the intravascular filter 10. In some embodiments, a pressurized fluid such as saline may be used to urge the intravascular filter 10 distally. As the intravascular filter 10 is urged out of the introducer sheath, it transforms into its deployed configuration. Figure 4 illustrates the intravascular filter 10 in a fully deployed configuration. In
Figure 4, it can be seen that the hooks or barbs 20 that are present at the free ends 19 of the filter legs 14 engage with a vessel wall 42 of the blood vessel 36.
Figure 5 illustrates the intravascular filter 10 deployed within a patient's vessel 36 in which blood flow is indicated by arrows 42. The apical head 12 and drug reservoir 22 is downstream of an open end of the intravascular filter 10 defined by the free ends 18 of the filter legs 14. An emboli 44 is seen moving towards the intravascular filter 10. As the emboli 44 moves closer, it will be guided by the filter legs 14 towards the center of the intravascular filter 10 and thus towards the drug reservoir 22. The drug reservoir may elute a therapeutic drug, such as those discussed above, in order to facilitate dissolution of the emboli 44.
The invention should not be considered limited to the particular examples described above, but rather should be understood to cover all aspects of the invention as set out in the attached claims. Various modifications, equivalent processes, as well as numerous structures to which the invention can be applicable will be readily apparent to those of skill in the art upon review of the instant specification.
Claims
1. An intravascular filter, comprising: a plurality of filter legs, each of the filter legs having a free end and an opposite joined end; an apical head, the joined end of each of the filter legs secured to the apical head, each of the filter legs radiating outwardly from the apical head; and a drug reservoir disposed near the apical head, the drug reservoir comprising a therapeutic drug.
2. The intravascular filter of claim 1 , wherein the therapeutic drug comprises a thrombolytic agent.
3. The intravascular filter of claim 2, wherein the thrombolytic agent comprises a drug selected from the group consisting of reteplase, alteplase, urokinase, prourokinase, anisoylated streptokinase activator complex, and streptokinase.
4. The intravascular filter of claim 1 , wherein the therapeutic drug comprises an anti-coagulant.
5. The intravascular filter of claim 4, wherein the anti-coagulant comprises one of heparin or Coumadin.
6. The intravascular filter of claim 1 , wherein the drug reservoir comprises the therapeutic drug dispersed within a polymer.
7. The intravascular filter of claim 6, wherein the polymer is configured to permit the therapeutic drug to elute from the polymer.
8. The intravascular filter of claim 6, wherein the polymer comprises poly(styrene-b-isoburylene-b-styrene).
9. The intravascular filter of claim 1, wherein the drug reservoir comprises a hollow volume containing the therapeutic drug.
10. The intravascular filter of claim 9, wherein the hollow volume comprises a cup positioned inside the plurality of filter legs, the cup having an open end and a closed end, where the closed end is positioned closest to the apical head while the open end extends away from the apical head.
11. The intravascular filter of claim 10, wherein the cup is formed of a polymer.
12. The intravascular filter of claim 10, wherein the cup is formed of a metal comprising one of stainless steel or nitinol.
13. The intravascular filter of claim 1 , wherein the plurality of filter legs comprise stainless steel.
14. The intravascular filter of claim 1 , wherein the apical head comprises stainless steel.
15. The intravascular filter of claim 1 , wherein the plurality of filter legs omprise nitinol.
16. The intravascular filter of claim 1, wherein the apical head comprises nitinol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/125,531 US8574259B2 (en) | 2005-05-10 | 2005-05-10 | Intravascular filter with drug reservoir |
US11/125,531 | 2005-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006122075A1 true WO2006122075A1 (en) | 2006-11-16 |
Family
ID=36954651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/017821 WO2006122075A1 (en) | 2005-05-10 | 2006-05-09 | Intravascular filter with drug reservoir |
Country Status (2)
Country | Link |
---|---|
US (1) | US8574259B2 (en) |
WO (1) | WO2006122075A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7314477B1 (en) | 1998-09-25 | 2008-01-01 | C.R. Bard Inc. | Removable embolus blood clot filter and filter delivery unit |
US9204956B2 (en) | 2002-02-20 | 2015-12-08 | C. R. Bard, Inc. | IVC filter with translating hooks |
US20060015137A1 (en) * | 2004-07-19 | 2006-01-19 | Wasdyke Joel M | Retrievable intravascular filter with bendable anchoring members |
US7704267B2 (en) | 2004-08-04 | 2010-04-27 | C. R. Bard, Inc. | Non-entangling vena cava filter |
US7794473B2 (en) | 2004-11-12 | 2010-09-14 | C.R. Bard, Inc. | Filter delivery system |
US8029529B1 (en) | 2005-01-19 | 2011-10-04 | C. R. Bard, Inc. | Retrievable filter |
US8267954B2 (en) | 2005-02-04 | 2012-09-18 | C. R. Bard, Inc. | Vascular filter with sensing capability |
US8025668B2 (en) | 2005-04-28 | 2011-09-27 | C. R. Bard, Inc. | Medical device removal system |
CA2607580C (en) | 2005-05-12 | 2016-12-20 | C.R. Bard Inc. | Removable embolus blood clot filter |
CA2616818C (en) | 2005-08-09 | 2014-08-05 | C.R. Bard, Inc. | Embolus blood clot filter and delivery system |
CA2630217C (en) | 2005-11-18 | 2016-10-11 | C.R. Bard, Inc. | Vena cava filter with filament |
JP2009519049A (en) * | 2005-12-02 | 2009-05-14 | シー・アール・バード・インコーポレイテツド | Spiral vena cava filter |
WO2007133366A2 (en) | 2006-05-02 | 2007-11-22 | C. R. Bard, Inc. | Vena cava filter formed from a sheet |
US9326842B2 (en) | 2006-06-05 | 2016-05-03 | C. R . Bard, Inc. | Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access |
US8795351B2 (en) | 2007-04-13 | 2014-08-05 | C.R. Bard, Inc. | Migration resistant embolic filter |
US20170136158A1 (en) * | 2015-10-16 | 2017-05-18 | Angiodynamics, Inc. | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
EP3505136A1 (en) | 2009-07-29 | 2019-07-03 | C.R. Bard Inc. | Tubular filter |
US20140276403A1 (en) * | 2013-03-13 | 2014-09-18 | DePuy Synthes Products, LLC | Ischemic stroke device |
US9808271B2 (en) | 2014-01-03 | 2017-11-07 | Legacy Ventures LLC | Clot retrieval system |
WO2017192825A1 (en) | 2016-05-06 | 2017-11-09 | Heartware, Inc. | Blood clot filter with local thrombolytic drug delivery |
USD916281S1 (en) * | 2016-10-17 | 2021-04-13 | Angiodynamics, Inc. | Reinforcement arms and collar for a cannula tip |
USD972723S1 (en) | 2021-03-17 | 2022-12-13 | Angiodynamics, Inc. | Reinforcement arms and collar for an expandable cannula tip |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002056796A1 (en) * | 2000-12-01 | 2002-07-25 | Nephros Therapeutics, Inc. | Intravascular blood conditioning device and use thereof |
US20030235602A1 (en) * | 2002-06-19 | 2003-12-25 | Schwarz Marlene C. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
EP1486182A2 (en) * | 1995-06-05 | 2004-12-15 | Nephros Therapeutics, Inc. | A device for delivering a preselected molecule into the systemic circulation |
Family Cites Families (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3334629A (en) * | 1964-11-09 | 1967-08-08 | Bertram D Cohn | Occlusive device for inferior vena cava |
US3467102A (en) * | 1967-04-18 | 1969-09-16 | Edwards Lab Inc | Leader type catheter |
US3540431A (en) * | 1968-04-04 | 1970-11-17 | Kazi Mobin Uddin | Collapsible filter for fluid flowing in closed passageway |
US3868956A (en) * | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
US3952747A (en) * | 1974-03-28 | 1976-04-27 | Kimmell Jr Garman O | Filter and filter insertion instrument |
US4391797A (en) * | 1977-01-05 | 1983-07-05 | The Children's Hospital Medical Center | Systems for the controlled release of macromolecules |
US4675361A (en) * | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
US4430081A (en) * | 1981-01-06 | 1984-02-07 | Cook, Inc. | Hemostasis sheath |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4487808A (en) * | 1982-04-22 | 1984-12-11 | Astra Meditec Aktiebolag | Medical article having a hydrophilic coating |
SE430696B (en) * | 1982-04-22 | 1983-12-05 | Astra Meditec Ab | PROCEDURE FOR THE PREPARATION OF A HYDROPHILIC COATING AND ANY PROCEDURE MANUFACTURED MEDICAL ARTICLE |
US5002582A (en) * | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
US4643184A (en) * | 1982-09-29 | 1987-02-17 | Mobin Uddin Kazi | Embolus trap |
US4494531A (en) | 1982-12-06 | 1985-01-22 | Cook, Incorporated | Expandable blood clot filter |
US4727873A (en) * | 1984-04-17 | 1988-03-01 | Mobin Uddin Kazi | Embolus trap |
DK151404C (en) * | 1984-05-23 | 1988-07-18 | Cook Europ Aps William | FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD |
US5037677A (en) * | 1984-08-23 | 1991-08-06 | Gregory Halpern | Method of interlaminar grafting of coatings |
US4959074A (en) * | 1984-08-23 | 1990-09-25 | Gergory Halpern | Method of hydrophilic coating of plastics |
FR2570288B1 (en) | 1984-09-14 | 1988-11-25 | Celsa Composants Electr Sa | FILTER, PARTICULARLY FOR THE RETENTION OF BLOOD CLOTS, ITS MANUFACTURING METHOD AND DEVICES FOR ITS PLACEMENT |
FR2573646B1 (en) * | 1984-11-29 | 1988-11-25 | Celsa Composants Electr Sa | PERFECTED FILTER, PARTICULARLY FOR THE RETENTION OF BLOOD CLOTS |
FR2580504B1 (en) | 1985-04-22 | 1987-07-10 | Pieronne Alain | FILTER FOR THE PARTIAL AND AT LEAST PROVISIONAL INTERRUPTION OF A VEIN AND CATHETER CARRYING THE FILTER |
US4662885A (en) * | 1985-09-03 | 1987-05-05 | Becton, Dickinson And Company | Percutaneously deliverable intravascular filter prosthesis |
US4650466A (en) * | 1985-11-01 | 1987-03-17 | Angiobrade Partners | Angioplasty device |
US4793348A (en) * | 1986-11-15 | 1988-12-27 | Palmaz Julio C | Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation |
FR2606641B1 (en) | 1986-11-17 | 1991-07-12 | Promed | FILTERING DEVICE FOR BLOOD CLOTS |
US5037656A (en) * | 1986-12-04 | 1991-08-06 | Millipore Corporation | Porous membrane having hydrophilic and cell growth promotions surface and process |
US4817600A (en) * | 1987-05-22 | 1989-04-04 | Medi-Tech, Inc. | Implantable filter |
US4873978A (en) * | 1987-12-04 | 1989-10-17 | Robert Ginsburg | Device and method for emboli retrieval |
FR2624747A1 (en) | 1987-12-18 | 1989-06-23 | Delsanti Gerard | REMOVABLE ENDO-ARTERIAL DEVICES FOR REPAIRING ARTERIAL WALL DECOLLEMENTS |
FR2632864B2 (en) * | 1987-12-31 | 1990-10-19 | Biomat Sarl | ANTI-EMBOLIC ELASTIC FILTERING SYSTEM FOR CELLAR VEIN AND ASSEMBLY OF MEANS FOR ITS PLACEMENT |
US4943460A (en) * | 1988-02-19 | 1990-07-24 | Snyder Laboratories, Inc. | Process for coating polymer surfaces and coated products produced using such process |
US4980231A (en) | 1988-02-19 | 1990-12-25 | Snyder Laboratories, Inc. | Process for coating polymer surfaces and coated products produced using such process |
US4925698A (en) * | 1988-02-23 | 1990-05-15 | Tekmat Corporation | Surface modification of polymeric materials |
FR2632848A1 (en) * | 1988-06-21 | 1989-12-22 | Lefebvre Jean Marie | FILTER FOR MEDICAL USE |
US4832055A (en) * | 1988-07-08 | 1989-05-23 | Palestrant Aubrey M | Mechanically locking blood clot filter |
DE3888685T2 (en) * | 1988-10-10 | 1994-10-20 | Ibm | Method for breaking a plate-shaped workpiece, in particular a semiconductor wafer, and device for breaking said workpiece sandwiched between two foils. |
US5152777A (en) * | 1989-01-25 | 1992-10-06 | Uresil Corporation | Device and method for providing protection from emboli and preventing occulsion of blood vessels |
US4969891A (en) * | 1989-03-06 | 1990-11-13 | Gewertz Bruce L | Removable vascular filter |
US5026607A (en) * | 1989-06-23 | 1991-06-25 | C. R. Bard, Inc. | Medical apparatus having protective, lubricious coating |
US5059205A (en) * | 1989-09-07 | 1991-10-22 | Boston Scientific Corporation | Percutaneous anti-migration vena cava filter |
US5242462A (en) * | 1989-09-07 | 1993-09-07 | Boston Scientific Corp. | Percutaneous anti-migration vena cava filter |
US5035706A (en) * | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
GB2238485B (en) | 1989-11-28 | 1993-07-14 | Cook William Europ | A collapsible filter for introduction in a blood vessel of a patient |
US5135516A (en) * | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
US5674192A (en) * | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5304121A (en) * | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
US5545208A (en) * | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
FR2660189B1 (en) * | 1990-03-28 | 1992-07-31 | Lefebvre Jean Marie | DEVICE INTENDED TO BE IMPLANTED IN A VESSEL WITH SIDE LEGS WITH ANTAGONIST TEETH. |
US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
AU7998091A (en) * | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
FR2663217B1 (en) * | 1990-06-15 | 1992-10-16 | Antheor | FILTERING DEVICE FOR THE PREVENTION OF EMBOLIES. |
CA2048307C (en) | 1990-08-14 | 1998-08-18 | Rolf Gunther | Method and apparatus for filtering blood in a blood vessel of a patient |
US5160342A (en) * | 1990-08-16 | 1992-11-03 | Evi Corp. | Endovascular filter and method for use thereof |
US5108419A (en) * | 1990-08-16 | 1992-04-28 | Evi Corporation | Endovascular filter and method for use thereof |
SE467308B (en) * | 1990-10-22 | 1992-06-29 | Berol Nobel Ab | SOLID SURFACE COATED WITH A HYDROPHILIC SURFACE WITH COVALENTLY BONDED BIOPOLYMERS, SET TO MAKE SUCH A SURFACE AND CONJUGATED THEREOF |
US5160790A (en) * | 1990-11-01 | 1992-11-03 | C. R. Bard, Inc. | Lubricious hydrogel coatings |
US5147379A (en) * | 1990-11-26 | 1992-09-15 | Louisiana State University And Agricultural And Mechanical College | Insertion instrument for vena cava filter |
US5102402A (en) * | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
AU1579092A (en) * | 1991-02-27 | 1992-10-06 | Nova Pharmaceutical Corporation | Anti-infective and anti-inflammatory releasing systems for medical devices |
DE69125828T2 (en) * | 1991-05-21 | 1997-07-31 | Hewlett Packard Gmbh | Process for pretreating the surface of a medical article |
US5330768A (en) * | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5626605A (en) * | 1991-12-30 | 1997-05-06 | Scimed Life Systems, Inc. | Thrombosis filter |
JP2573612Y2 (en) | 1991-12-30 | 1998-06-04 | ハナコメディカル株式会社 | Filter for thrombus filtration |
US5599352A (en) * | 1992-03-19 | 1997-02-04 | Medtronic, Inc. | Method of making a drug eluting stent |
US5383928A (en) * | 1992-06-10 | 1995-01-24 | Emory University | Stent sheath for local drug delivery |
US5324304A (en) * | 1992-06-18 | 1994-06-28 | William Cook Europe A/S | Introduction catheter set for a collapsible self-expandable implant |
US5578075B1 (en) * | 1992-11-04 | 2000-02-08 | Daynke Res Inc | Minimally invasive bioactivated endoprosthesis for vessel repair |
US5449382A (en) * | 1992-11-04 | 1995-09-12 | Dayton; Michael P. | Minimally invasive bioactivated endoprosthesis for vessel repair |
US5443458A (en) * | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
US5419760A (en) * | 1993-01-08 | 1995-05-30 | Pdt Systems, Inc. | Medicament dispensing stent for prevention of restenosis of a blood vessel |
WO1994021308A1 (en) * | 1993-03-18 | 1994-09-29 | Cedars-Sinai Medical Center | Drug incorporating and releasing polymeric coating for bioprosthesis |
US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
US5994341A (en) * | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
EP0711158B2 (en) * | 1993-07-29 | 2008-07-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
US5380299A (en) * | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
US5626862A (en) * | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
US5601595A (en) * | 1994-10-25 | 1997-02-11 | Scimed Life Systems, Inc. | Remobable thrombus filter |
US5709704A (en) * | 1994-11-30 | 1998-01-20 | Boston Scientific Corporation | Blood clot filtering |
US6214025B1 (en) * | 1994-11-30 | 2001-04-10 | Boston Scientific Corporation | Self-centering, self-expanding and retrievable vena cava filter |
US5702754A (en) | 1995-02-22 | 1997-12-30 | Meadox Medicals, Inc. | Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings |
US5605696A (en) * | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US5837313A (en) * | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US20020193828A1 (en) * | 2001-06-14 | 2002-12-19 | Cook Incorporated | Endovascular filter |
US5722984A (en) * | 1996-01-16 | 1998-03-03 | Iso Stent, Inc. | Antithrombogenic radioactive coating for an intravascular stent |
ATE314843T1 (en) | 1996-03-12 | 2006-02-15 | Pg Txl Co Lp | WATER SOLUBLE PACLITAXEL PRODRUGS |
US5669933A (en) * | 1996-07-17 | 1997-09-23 | Nitinol Medical Technologies, Inc. | Removable embolus blood clot filter |
US5800525A (en) * | 1997-06-04 | 1998-09-01 | Vascular Science, Inc. | Blood filter |
US6156373A (en) | 1999-05-03 | 2000-12-05 | Scimed Life Systems, Inc. | Medical device coating methods and devices |
US6273901B1 (en) * | 1999-08-10 | 2001-08-14 | Scimed Life Systems, Inc. | Thrombosis filter having a surface treatment |
US6602271B2 (en) * | 2000-05-24 | 2003-08-05 | Medtronic Ave, Inc. | Collapsible blood filter with optimal braid geometry |
US6468290B1 (en) * | 2000-06-05 | 2002-10-22 | Scimed Life Systems, Inc. | Two-planar vena cava filter with self-centering capabilities |
US20040073252A1 (en) * | 2001-02-20 | 2004-04-15 | Mark Goldberg | Blood clot filtering system |
US7214237B2 (en) * | 2001-03-12 | 2007-05-08 | Don Michael T Anthony | Vascular filter with improved strength and flexibility |
US6746469B2 (en) * | 2001-04-30 | 2004-06-08 | Advanced Cardiovascular Systems, Inc. | Balloon actuated apparatus having multiple embolic filters, and method of use |
US6878153B2 (en) * | 2001-07-02 | 2005-04-12 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection and removing embolic material |
US7108701B2 (en) * | 2001-09-28 | 2006-09-19 | Ethicon, Inc. | Drug releasing anastomosis devices and methods for treating anastomotic sites |
US7192434B2 (en) * | 2002-03-08 | 2007-03-20 | Ev3 Inc. | Vascular protection devices and methods of use |
US7534251B2 (en) * | 2003-02-11 | 2009-05-19 | Boston Scientific Scimed, Inc. | Retrievable IVC filter |
-
2005
- 2005-05-10 US US11/125,531 patent/US8574259B2/en not_active Expired - Fee Related
-
2006
- 2006-05-09 WO PCT/US2006/017821 patent/WO2006122075A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1486182A2 (en) * | 1995-06-05 | 2004-12-15 | Nephros Therapeutics, Inc. | A device for delivering a preselected molecule into the systemic circulation |
WO2002056796A1 (en) * | 2000-12-01 | 2002-07-25 | Nephros Therapeutics, Inc. | Intravascular blood conditioning device and use thereof |
US20030235602A1 (en) * | 2002-06-19 | 2003-12-25 | Schwarz Marlene C. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
Also Published As
Publication number | Publication date |
---|---|
US20060259067A1 (en) | 2006-11-16 |
US8574259B2 (en) | 2013-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8574259B2 (en) | Intravascular filter with drug reservoir | |
CA2512451C (en) | Embolic protection device | |
US10258487B2 (en) | Stents having protruding drug-delivery features and associated systems and methods | |
US20190374356A1 (en) | Highly Flexible Stent And Method Of Manufacture | |
EP1635733B1 (en) | Sandwiched radiopaque marker on covered stent | |
US8361103B2 (en) | Low profile IVC filter | |
CA2503108C (en) | Locking stent having multiple locking points | |
US20120083823A1 (en) | Apparatus for filtering a body lumen | |
WO2006007325A1 (en) | Intravascular filter | |
US20090264982A1 (en) | Stent with auxiliary treatment structure | |
EP4005537A1 (en) | Highly flexible stent and method of manufacture | |
WO2008100783A2 (en) | Highly flexible stent and method of manufacture | |
US20110106135A1 (en) | Indwelling Temporary IVC Filter System With Drug Delivery and Aspiration | |
US20120035646A1 (en) | Bistable body lumen filter anchors | |
EP3435929B1 (en) | Contracting stent with bioresorbable struts | |
US20120035647A1 (en) | Body lumen filters with large surface area anchors | |
US9320630B2 (en) | Implant delivery assembly and method of use | |
US20230263648A1 (en) | Drug elution for implantable medical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06752416 Country of ref document: EP Kind code of ref document: A1 |